Hemostemix (HEM) Stock Chart & Stock Price History C$0.10 +0.01 (+11.11%) (As of 11/4/2024 05:19 PM ET) Add Compare Share Share Chart Stock AnalysisChartHeadlinesInsider Trades Hemostemix Stock Price Performance5 Day Performance0.00%1 Month Performance+53.85%3 Month Performance+100.00%6 Month Performance+150.00%Year-To-Date Performance+42.86%1 Year Performance+33.33% Receive HEM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Hemostemix and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Timothy SykesTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…Click here to see a unique election-year trade HEM Stock Chart for Tuesday, November, 5, 2024 HEM Chart by TradingView Hemostemix Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/01/2024C$0.09C$0.10+11.11%C$0.10C$0.1065,000 shsC$8.71 million10/31/2024C$0.10C$0.09-10.00%C$0.10C$0.0920,500 shsC$7.84 million10/30/2024C$0.10C$0.10C$0.10C$0.1031,515 shsC$8.71 million10/29/2024C$0.09C$0.10+11.11%C$0.10C$0.0996,000 shsC$8.71 million10/28/2024C$0.11C$0.09-14.29%C$0.09C$0.0993,450 shsC$7.84 million10/25/2024C$0.10C$0.11+5.00%C$0.11C$0.0915,850 shsC$9.15 million Get the Latest News and Ratings for HEM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Hemostemix and its competitors with MarketBeat's FREE daily newsletter. 10/24/2024C$0.10C$0.10C$0.10C$0.10156,100 shsC$8.71 million10/23/2024C$0.10C$0.10C$0.10C$0.0914,000 shsC$8.71 million10/22/2024C$0.10C$0.10C$0.10C$0.0961,000 shsC$8.71 million10/21/2024C$0.09C$0.10+11.11%C$0.10C$0.0994,000 shsC$8.71 million10/18/2024C$0.08C$0.09+12.50%C$0.09C$0.0852,000 shsC$7.84 million10/17/2024C$0.07C$0.08+23.08%C$0.08C$0.07202,500 shsC$6.97 million10/16/2024C$0.07C$0.07C$0.07C$0.0767,000 shsC$5.66 million10/15/2024C$0.06C$0.07+8.33%C$0.07C$0.07150,220 shsC$5.66 million10/14/2024C$0.06C$0.06C$0.08C$0.06602,000 shsC$5.23 million10/11/2024C$0.06C$0.06C$0.08C$0.06602,000 shsC$5.23 million10/10/2024C$0.06C$0.06C$0.07C$0.06480,000 shsC$5.23 million10/09/2024C$0.06C$0.06C$0.07C$0.061,480 shsC$5.23 million10/08/2024C$0.07C$0.06-14.29%C$0.07C$0.06523,322 shsC$5.23 million10/07/2024C$0.07C$0.07+7.69%C$0.07C$0.061.74 million shsC$6.10 million10/04/2024C$0.08C$0.07-18.75%C$0.09C$0.071.90 million shsC$5.66 million10/03/2024C$0.11C$0.08-23.81%C$0.10C$0.08379,999 shsC$6.97 million10/02/2024C$0.09C$0.11+16.67%C$0.11C$0.09282,130 shsC$9.15 million10/01/2024C$0.10C$0.09-5.26%C$0.09C$0.0920,000 shsC$7.84 million09/30/2024C$0.10C$0.10-5.00%C$0.10C$0.105,000 shsC$8.28 million09/27/2024C$0.10C$0.10+5.26%C$0.10C$0.1018,000 shsC$8.71 million09/26/2024C$0.10C$0.10C$0.10C$0.1068,100 shsC$8.28 million09/25/2024C$0.10C$0.10C$0.10C$0.09192,000 shsC$8.28 million09/24/2024C$0.10C$0.10C$0.10C$0.0910,000 shsC$8.28 million09/23/2024C$0.10C$0.10C$0.10C$0.0929,500 shsC$8.28 million09/20/2024C$0.09C$0.10+11.76%C$0.10C$0.09113,000 shsC$8.28 million09/19/2024C$0.09C$0.09C$0.09C$0.0940,200 shsC$7.41 million09/18/2024C$0.09C$0.09-5.56%C$0.09C$0.0813,500 shsC$7.41 million09/17/2024C$0.09C$0.09C$0.09C$0.08227,700 shsC$7.84 million09/16/2024C$0.09C$0.09+5.88%C$0.09C$0.0970,000 shsC$7.84 million09/13/2024C$0.08C$0.09+6.25%C$0.09C$0.0892,000 shsC$7.41 million09/12/2024C$0.08C$0.08C$0.08C$0.08311,533 shsC$6.97 million09/11/2024C$0.07C$0.08+14.29%C$0.08C$0.0879,500 shsC$6.97 million09/10/2024C$0.07C$0.07C$0.07C$0.077,100 shsC$6.10 million09/09/2024C$0.08C$0.07-6.67%C$0.08C$0.0799,500 shsC$6.10 millionBlackrock’s Sending THIS Crypto Higher on Purpose (Ad)It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW09/06/2024C$0.07C$0.08+15.38%C$0.09C$0.07439,759 shsC$6.53 million09/05/2024C$0.06C$0.07+18.18%C$0.07C$0.06476,500 shsC$5.66 million09/04/2024C$0.07C$0.06-21.43%C$0.06C$0.0515,000 shsC$4.79 million09/03/2024C$0.07C$0.07C$0.07C$0.071,500 shsC$6.10 million09/02/2024C$0.07C$0.07C$0.07C$0.0660,734 shsC$6.10 million08/30/2024C$0.06C$0.07+16.67%C$0.07C$0.0660,734 shsC$6.10 million08/29/2024C$0.05C$0.06+20.00%C$0.06C$0.06143,300 shsC$5.23 million08/28/2024C$0.06C$0.05-9.09%C$0.05C$0.0530,000 shsC$4.36 million08/27/2024C$0.06C$0.06C$0.06C$0.06138,001 shsC$4.79 million08/26/2024C$0.07C$0.06-15.38%C$0.06C$0.06138,001 shsC$4.79 million08/23/2024C$0.05C$0.07+30.00%C$0.07C$0.05503,000 shsC$5.66 million08/22/2024C$0.05C$0.05+11.11%C$0.05C$0.0463,000 shsC$4.36 million08/21/2024C$0.05C$0.05C$0.05C$0.0423,000 shsC$3.92 million08/20/2024C$0.05C$0.05-10.00%C$0.05C$0.055,244 shsC$3.92 million08/19/2024C$0.05C$0.05C$0.05C$0.052,000 shsC$4.36 million08/16/2024C$0.05C$0.05+11.11%C$0.05C$0.052,000 shsC$4.36 million08/15/2024C$0.05C$0.05C$0.05C$0.0427,000 shsC$3.92 million08/14/2024C$0.05C$0.05C$0.05C$0.0427,000 shsC$3.92 million08/13/2024C$0.05C$0.05C$0.05C$0.0510,000 shsC$3.92 million08/12/2024C$0.05C$0.05-10.00%C$0.05C$0.0523,900 shsC$3.92 million08/09/2024C$0.05C$0.05C$0.05C$0.053,000 shsC$4.36 million08/08/2024C$0.06C$0.05-9.09%C$0.05C$0.0530,600 shsC$4.36 million08/07/2024C$0.06C$0.06C$0.06C$0.061,000 shsC$4.79 million08/06/2024C$0.05C$0.06+10.00%C$0.06C$0.0510,000 shsC$4.79 million08/05/2024C$0.05C$0.05C$0.05C$0.05189,000 shsC$4.36 million Related Companies Resverlogix Stock Price Chart Ceapro Stock Price Chart Kane Biotech Stock Price Chart Devonian Health Group Stock Price Chart Aeterna Zentaris Stock Price Chart Sirona Biochem Stock Price Chart Aptose Biosciences Stock Price Chart Innovotech Stock Price Chart Quest PharmaTech Stock Price Chart Fennec Pharmaceuticals Stock Price Chart Receive HEM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Hemostemix and its competitors with MarketBeat's FREE daily newsletter. This page (CVE:HEM) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredMissed Out On Nvidia?Artificial Intelligence is a tool with the potential to create massive distributions of wealth… In fact, it...Unstoppable Prosperity | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredCrypto Crash Ahead? (27 Experts Weigh In)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Crypto 101 Media | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hemostemix Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hemostemix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
